Sotera Health Smashes Q1 Revenue Expectations

Sotera Healths Q1 2026 results surpassed expectations, with revenue hitting $280M, a 10% increase from last year, and adjusted EPS at $0.18. Adjusted EBITDA of $134.7M topped forecasts by 2.5%. The stock surged 7.2% to $16.50. Investors praised the 6.5% organic revenue growth. Despite past slowdowns, Soteras efficiency push bodes well for future growth, with analysts predicting 5.5% revenue growth over the next year. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/11422f0bb045f99f